|
|
China is expected to emerge as the world's fifth-largest national market for pharmaceuticals by the year 2010. Capabilities in chemistry and clinical research are already well-established with rapid growth in biology and preclinical development. Frontier Biosciences' strong relationship with major hospitals and key decision-makers improve your chances of faster approvals, advantageous pricing, and speedier access to the market. Our management force has extensive experience in working with Chinese regulatory agencies. On your behalf, our staff will negotiate language, cultural, IP, and regulatory differences, to achieve efficient importation and registration of your drug.
|
|
| |
